Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anixa Biosciences Inc Director's Dealing 2012

Sep 5, 2012

34117_dirs_2012-09-05_55964ede-0066-4b35-8898-d6c54327b4a7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2012-08-29

Reporting Person: JOHNSON BRUCE F (Director)

Holdings (Non-Derivative)

Security Shares Ownership
CopyTele, Inc. common stock 4079188 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Employee Stock Options (Right to Buy) $0.12 2017-08-30 Common Stock (60000) Direct
Common Stock Purchase Warrant $0.1786 2016-02-07 Common Stock (700000) Direct

Footnotes

F1: Pursuant to CopyTele, Inc. 2010 Share Incentive Plan.

F2: Pursuant to a private placement by CopyTele, Inc. in February 2011.